Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

News

      US FDA Launches Fast-Track Review Scheme for Generic Drugs

      The FDA has introduced a pilot fast-track review programme aimed at accelerating reviews for generic medicines tested and manufactured within the United States, marking...

      Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

      Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals have joined forces in a new collaboration that seeks to harness artificial intelligence to accelerate drug...

      AbbVie Launches New API Manufacturing Facility in Illinois

      AbbVie has started construction of a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, a critical milestone in its strategy to...

      Amgen to Expand U.S. Manufacturing with $650M Investment

      Amgen has announced a $650 million expansion of its U.S. manufacturing facilities, a development that will create almost 750 new positions. The expansion will...

      US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

      Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval for Inluriyo (imlunestrant, 200 mg tablets), an oral estrogen receptor antagonist....

      Lilly to Build $6.5B API Manufacturing Facility in Houston

      Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, described as a next-generation...

      US FDA to Approve Leucovorin for Cerebral Folate Deficiency

      The U.S. Food and Drug Administration (FDA) has started the process to approve leucovorin calcium tablets as a treatment for patients with cerebral folate...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...